Resmed (RMD) announced its home sleep apnea test, NightOwl, is now available across the United States. NightOwl is an FDA-cleared home sleep ...

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re ...

Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed ... We provide a platform for our authors to report on investments fairly, accurately, and from the investor ...

The global sleep apnea devices market report consists of exclusive data on 39 vendors. The competitive landscape of sleep apnea devices is dynamic, w ...

ResMed’s primary focus is sleep technology – it provides cloud ... helped this quarter by an August earnings report that showed steady sales and improving profitability. That said, the stock ...

Thrivent Financial for Lutherans cut its stake in ResMed Inc. (NYSE:RMD – Free Report) by 0.9% during the 4th quarter, ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?